Eris Lifesciences Limited (ERIS.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 177.29B |
| Enterprise Value | 200.2B |
| P/E Ratio | 31.64 |
| PEG Ratio | 0.42 |
| Price/Sales Ratio | 6.36 |
| Price/Book Ratio | 5.03 |
| Enterprise/Revenue | 7.09 |
| Enterprise/EBITDA | 19.99 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.2 |
| Operating Margin | 0.27 |
AD
Management Effectiveness
| Return On Assets | 0.08 |
| Return On Equity | 0.19 |
Income Statement
| Revenue | 31.29B |
| Revenue/Share | 228.92 |
| Gross Profit | 14.98B |
| EBITDA | 11.11B |
| Net Income | 6.2B |
| Diluted EPS | 45.33 |
Balance Sheet
| Total Cash | 763.8M |
| Total Cash/Share | 4.92 |
| Total Debt | 23.59B |
| Total Debt/Equity | 0.6 |
| Current Ratio | 0.74 |
| Book Value Per Share | 284.97 |
Price History
| 52-Week Change | -11.5 |
| 52-Week High | 1,885 |
| 52-Week Low | 1,200 |
| Moving Average 50 Days | 1,378.19 |
| Moving Average 200 Days | 1,471.27 |
Statistics
| Average Volume | 130,829 |
| Shares Outstanding | 138.57M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 7.21 |
| Trailing Annual Dividend Yield | 0.5 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
